Criteria for discontinuing or modifying allocated interventions
Subjects can leave the study at any time for any reason if they wish to do so without any consequences. The investigator can decide to withdraw a subject from the study for urgent medical reasons. Participants who received placebo will be unblinded at the end of the study and pending a recommendation by the data safety monitoring board (DSMB), they will be offered the option of receiving the BCG intervention.